CXCR4/AT1信号轴影响肾足细胞与系膜细胞交流的调控机制研究
批准号:
82100786
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
武秦羽
依托单位:
学科分类:
慢性肾脏病及其并发症
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
武秦羽
中文摘要
肾小球损伤以肾小球滤过屏障受损和系膜基质扩张为特征,这一表现主要由足细胞损伤和系膜细胞活化引起。但是两者相互交流的潜在机制鲜少报道。我们前期发现在肾小球疾病中,趋化因子受体CXCR4特异性高表达于足细胞,其配体SDF-1α特异性高表达于系膜细胞并可靶向足细胞诱导足细胞损伤;我们进一步发现足细胞中CXCR4的上调伴随着血管紧张素II(AngII)的产生,而其受体AT1高表达于系膜细胞。据此我们提出:足细胞损伤早期可致CXCR4表达上调并合成大量AngII,AngII可通过旁分泌作用于系膜细胞并与其配体AT1结合引起系膜细胞活化及合成大量SDF-1α,SDF-1α可进一步作用于足细胞加重足细胞损伤。本项目拟通过构建足细胞特异性CXCR4基因敲除小鼠并采用足细胞和系膜细胞系,深入探索CXCR4/AT1信号轴促进肾小球损伤的致病机制。本项目为肾小球疾病的致病机制提供新的理论依据及新的干预靶点。
英文摘要
Glomerular injury is characterized by the deficiency of glomerular filtration barrier and expansion of mesangial matrix, which mainly results from podocyte injury and mesangial cell activation. However, the underlying mechanisms of crosstalk between podocyte and mesangial cell are rarely reported. Previously, we found that the expression of CXCR4 in glomerular diseases was progressively upregulated, and especially in podocytes. While its ligand SDF-1α was primarily upregulated in mesangial cells and further triggered podocyte injury. We then found that the upregulation of CXCR4 in podocytes was accompanied by the production of AngiotensinII(AngII), while its receptor type 1 angiotensin receptor (AT1) was primarily upregulated in mesangial cells. Based on our previous studies, we hypothesize that podocyte CXCR4 could be upregulated in the early stage of podocyte injury and further lead to the secretion of AngII. AngII could bind to AT1 receptor and trigger mesangial cell activation in a paracrine manner. Meanwhile, SDF-1α is produced in mesangial cell, then is secreted to podocyte and binds to CXCR4 to aggravate podocyte injury. In this study, we will explore the pathogenic mechanism by which CXCR4/AT1 axis promotes glomerular injury in vivo and vitro by adopting podocyte-specific CXCR4 knockout mice,podocyte and mesangial cell lines. This study provides a new theoretical basis for the pathogenic mechanism of glomerular diseases and a novel target of intervention for glomerular diseases.
肾小球损伤以肾小球滤过屏障受损和系膜基质扩张为特征,这一表现主要由足细胞损伤和系膜细胞活化引起。但是两者相互交流的潜在机制鲜少报道。因此,我们研究了趋化因子受体 CXCR4和血管紧张素 II受体1(AT1)在足细胞和系膜细胞相互交流中所起的作用。我们建立CXCR4足细胞特异性敲除小鼠 ADR模型、野生型小鼠CKD( ADR、5/6肾切除)模型,同时体外培养足细胞MPC5及系膜细胞RMC。利用CXCR4过表达质粒pFlag-CXCR4、晚期氧化蛋白产物(AOPPs),AT1 阻断剂洛沙坦、CXCR4-shRNA、NOX4-shRNA进行干预。通过免疫印迹、 免疫组化、 免疫荧光等方法明确 CXCR4-AT1信号轴在足细胞和系膜细胞相互交流中的作用。我们发现在肾小球疾病模型中,CXCR4和AngII主要表达在受损的足细胞中。随着疾病的进展,AT1和基质细胞衍生因子1α(SDF-1α)(CXCR4的配体)在系膜细胞中表达上调。足细胞特异性敲除CXCR4可显著缓解足细胞损伤和系膜细胞活化。过表达CXCR4或应用AOPPs显著加重5/6肾切除小鼠的足细胞及肾小球硬化损伤。应用洛沙坦可阻断由 CXCR4 触发的足细胞损伤和系膜基质沉积。体外实验中,过表达CXCR4诱导足细胞氧化应激和肾素血管紧张素系统(RAS)活化,并触发足细胞与系膜细胞之间的通讯交流。AngII诱导系膜细胞表达大量SDF-1α,并分泌于上清中,进一步作用于足细胞加重足细胞损伤。综上所述,足细胞CXCR4通过活化NADPH 氧化酶诱导RAS系统激活及AngII分泌。足细胞AngII 通过旁分泌作用于系膜细胞,与其受体 AT1 特异性结合,诱导系膜细胞活化与系膜区基质沉积,并进一步诱导系膜细胞SDF-1α的表达, SDF-1α 可通过旁分泌效应靶向足细胞,与受体CXCR4结合加重足细胞损伤,形成恶性循环。我们的研究发现了肾小球疾病发生发展新的分子机制, 为慢性肾脏病的进展机制提供新信息,为防治肾小球疾病提供新的干预靶标。
国内基金
海外基金